{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:47:34Z","timestamp":1787507254933,"version":"build-2736575974"},"reference-count":130,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A significant proportion of patients with atrial fibrillation (AF) who need thromboembolic protection are not treated with or discontinue oral anticoagulation after its initiation. Undertreatment in clinical practice has not improved sufficiently despite the availability of direct oral anticoagulants, which are associated with less intracranial bleeding than vitamin K antagonists. Multiple reasons account for this phenomenon, including bleeding events or ischemic strokes while on anticoagulation, poor treatment adherence despite best educational attempts, or aversion to drug therapy. Percutaneous left atrial appendage (LAA) closure was introduced as an alternative to pharmacological therapy in AF patients in the early 2000s. Due to significant improvements in procedural safety over the years, left atrial appendage closure (LAAC), predominantly achieved through a percutaneous catheter-based device implantation approach, is increasingly favoured for preventing thromboembolic events in patients who cannot achieve effective anticoagulation or have a high hemorrhagic risk. This focused summary and update of a recently published practical guide, developed within guideline\/guidance boundaries, provides a perspective of current evidence of potential indications, benefits, complications and limitations of LAAC for neurologists and stroke physicians who may consider this increasingly utilised therapy.<\/jats:p>","DOI":"10.1093\/esj\/aakaf018","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T11:02:29Z","timestamp":1768906949000},"source":"Crossref","is-referenced-by-count":2,"title":["Update on left atrial appendage closure for neurologists"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6389-5054","authenticated-orcid":false,"given":"Karl Georg","family":"Haeusler","sequence":"first","affiliation":[{"name":"Department of Neurology, Universit\u00e4tsklinikum Ulm , Ulm ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6425-9343","authenticated-orcid":false,"given":"Luciano A","family":"Sposato","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurological Sciences, Western University , London, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1134-7099","authenticated-orcid":false,"given":"Marek","family":"Grygier","sequence":"additional","affiliation":[{"name":"Chair and 1st Department of Cardiology, Poznan University of Medical Sciences , Poznan ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-6902","authenticated-orcid":false,"given":"Tatjana","family":"Potpara","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade , Belgrade,","place":["Serbia"]},{"name":"University Clinical Centre of Serbia , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6473-2900","authenticated-orcid":false,"given":"Jens Erik","family":"Nielsen-Kudsk","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital , Aarhus ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4591-4220","authenticated-orcid":false,"given":"Lucas V A","family":"Boersma","sequence":"additional","affiliation":[{"name":"Cardiology Department, St. Antonius Hospital Nieuwegein\/Amsterdam University Medical Centers , Nieuwegein,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital , Liverpool ,","place":["United Kingdom"]},{"name":"Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University , Aalborg ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-9509","authenticated-orcid":false,"given":"Renate B","family":"Schnabel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Centre Hamburg , Hamburg ,","place":["Germany"]},{"name":"German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg\/Kiel\/L\u00fcbeck , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0482-4448","authenticated-orcid":false,"given":"Pavel","family":"Osmancik","sequence":"additional","affiliation":[{"name":"Department of Arrhythmology, University Hospital Kralovske Vinohrady , Prague ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5347-9906","authenticated-orcid":false,"given":"Boris","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Cardioangiologisches Centrum Bethanien, Agaplesion Markus Krankenhaus , Frankfurt,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7598-708X","authenticated-orcid":false,"given":"Wolfram","family":"D\u00f6hner","sequence":"additional","affiliation":[{"name":"Berlin Institute of Health-Center for Regenerative Therapies , Berlin ,","place":["Germany"]},{"name":"Deutsches Herzzentrum der Charit\u00e9, Campus Virchow Klinikum , Berlin ,","place":["Germany"]},{"name":"German Centre for Cardiovascular Research (DZHK) - partner site Berlin, Charit\u00e9 - Universit\u00e4tsmedizin Berlin , Berlin,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2007-888X","authenticated-orcid":false,"given":"Jan","family":"Kovac","sequence":"additional","affiliation":[{"name":"Leicester NIHR BRU, University of Leicester, Glenfield Hospital , Leicester ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2536-2871","authenticated-orcid":false,"given":"A John","family":"Camm","sequence":"additional","affiliation":[{"name":"City St. George\u2019s University of London , London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,1]]},"reference":[{"key":"2026012115130926900_ref1","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"2026012115130926900_ref2","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"2026012115130926900_ref3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012115130926900_ref4","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026012115130926900_ref5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/europace\/euad226","article-title":"Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal","volume":"25","author":"Lip","year":"2023","journal-title":"Europace"},{"key":"2026012115130926900_ref6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association joint Committee on clinical practice guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026012115130926900_ref7","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2026012115130926900_ref8","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1001\/jama.2021.21222","article-title":"Association of Rivaroxaban vs Apixaban with major ischemic or hemorrhagic events in patients with atrial fibrillation","volume":"326","author":"Ray","year":"2021","journal-title":"JAMA"},{"key":"2026012115130926900_ref9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1056\/NEJMoa2406674","article-title":"Abelacimab versus rivaroxaban in patients with atrial fibrillation","volume":"392","author":"Ruff","year":"2025","journal-title":"N Engl J Med"},{"key":"2026012115130926900_ref10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa2407105","article-title":"Asundexian versus apixaban in patients with atrial fibrillation","volume":"392","author":"Piccini","year":"2025","journal-title":"N Engl J Med"},{"key":"2026012115130926900_ref11","doi-asserted-by":"publisher","first-page":"iii46","DOI":"10.1093\/eurheartjsupp\/suaf015","article-title":"Factor XI inhibitors and atrial fibrillation: imminent breakthrough or false start?","volume":"27","author":"Raffo","year":"2025","journal-title":"Eur Heart J Suppl"},{"key":"2026012115130926900_ref12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/europace\/euz212","article-title":"The left atrial appendage in humans: structure, physiology, and pathogenesis","volume":"22","author":"Karim","year":"2020","journal-title":"Europace"},{"key":"2026012115130926900_ref13","doi-asserted-by":"publisher","first-page":"e25567","DOI":"10.7759\/cureus.25567","article-title":"National yearly trend of utilization and procedural complication of the Watchman device in the United States","volume":"14","author":"Shrestha","year":"2022","journal-title":"Cureus"},{"key":"2026012115130926900_ref14","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR left atrial appendage occlusion registry","volume":"75","author":"Freeman","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026012115130926900_ref15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/europace\/euad067","article-title":"Leap or lag: left atrial appendage closure and guidelines","volume":"25","author":"Camm","year":"2023","journal-title":"Europace"},{"key":"2026012115130926900_ref16","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae035","article-title":"Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper","volume":"26","author":"Potpara","year":"2024","journal-title":"Europace"},{"key":"2026012115130926900_ref17","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"2026012115130926900_ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026012115130926900_ref19","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026012115130926900_ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026012115130926900_ref21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jce.13362","article-title":"Safety profiles of percutaneous left atrial appendage closure devices: an analysis of the Food and Drug Administration manufacturer and user facility device experience (MAUDE) database from 2009 to 2016","volume":"29","author":"Jazayeri","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026012115130926900_ref22","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1016\/j.hrthm.2024.05.030","article-title":"Ischemic stroke severity and mortality after left atrial appendage closure vs nonwarfarin oral anticoagulants in patients with prior stroke","volume":"21","author":"Turagam","year":"2024","journal-title":"Heart Rhythm"},{"key":"2026012115130926900_ref23","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1016\/j.hrthm.2025.04.029","article-title":"Comparison of left atrial appendage closure and oral anti-coagulation after catheter ablation for atrial fibrillation: concomitant and sequential cohorts of the OPTION randomized controlled trial","volume":"22","author":"Saliba","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026012115130926900_ref24","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER cardiac plug","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"key":"2026012115130926900_ref25","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur Heart J"},{"key":"2026012115130926900_ref26","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"2026012115130926900_ref27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jcin.2022.02.009","article-title":"Clinical outcomes at 1 year following transcatheter left atrial appendage occlusion in the United States","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2026012115130926900_ref28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026295","article-title":"Two-year outcomes with a next-generation left atrial appendage device: final results of the PINNACLE FLX trial","volume":"12","author":"Doshi","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026012115130926900_ref29","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.hrthm.2016.01.022","article-title":"Short and long-term outcomes of percutaneous left atrial appendage suture ligation: results from a US multicenter evaluation","volume":"13","author":"Lakkireddy","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026012115130926900_ref30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/eurheartj\/ehac544.2137","article-title":"Trends in percutaneous left atrial appendage occlusion and 1-year mortality: a nationwide cohort study","volume":"43","author":"Juhl Madsen","year":"2022","journal-title":"Eur Heart J"},{"key":"2026012115130926900_ref31","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1001\/jama.2018.6024","article-title":"Association of Surgical Left Atrial Appendage Occlusion with subsequent stroke and mortality among patients undergoing cardiac surgery","volume":"319","author":"Yao","year":"2018","journal-title":"JAMA"},{"key":"2026012115130926900_ref32","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N Engl J Med"},{"key":"2026012115130926900_ref33","doi-asserted-by":"publisher","first-page":"100998","DOI":"10.1016\/j.ijcha.2022.100998","article-title":"Outcomes of cardiac surgery with left atrial appendage occlusion versus no occlusion, direct oral anticoagulants, and vitamin K antagonists: a systematic review with meta-analysis","volume":"40","author":"Nso","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2026012115130926900_ref34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/europace\/euw141","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2017","journal-title":"Europace"},{"key":"2026012115130926900_ref35","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1093\/eurheartj\/ehad203","article-title":"Ischaemic stroke in atrial fibrillation patients while on oral anticoagulation-a call for A-C-T-I-O-N","volume":"44","author":"Kg","year":"2023","journal-title":"Eur Heart J"},{"key":"2026012115130926900_ref36","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"key":"2026012115130926900_ref37","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.hlc.2018.06.1043","article-title":"National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018","volume":"27","author":"NHFA CSANZ Atrial Fibrillation Guideline Working Group","year":"2018","journal-title":"Heart Lung Circ"},{"key":"2026012115130926900_ref38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the Management of Patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012115130926900_ref39","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.cjca.2020.09.001","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Comprehensive guidelines for the Management of Atrial Fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"key":"2026012115130926900_ref40","doi-asserted-by":"publisher","first-page":"020","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"key":"2026012115130926900_ref41","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jcin.2023.01.011","article-title":"SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure","volume":"16","author":"Saw","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2026012115130926900_ref42","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association joint Committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2023","journal-title":"Circulation"},{"key":"2026012115130926900_ref43","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/17474930241312649","article-title":"Ischemic stroke prevention in patients with atrial fibrillation and a recent ischemic stroke, TIA, or intracranial hemorrhage: a World Stroke Organization (WSO) scientific statement","volume":"20","author":"Sposato","year":"2025","journal-title":"Int J Stroke"},{"key":"2026012115130926900_ref44","doi-asserted-by":"publisher","first-page":"103783","DOI":"10.1016\/j.jscai.2025.103783","article-title":"2025 SCAI\/HRS clinical practice guidelines on transcatheter left atrial appendage occlusion","volume":"4","author":"Goldsweig","year":"2025","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"2026012115130926900_ref45","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"key":"2026012115130926900_ref46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"22","author":"Glikson","year":"2020","journal-title":"Europace"},{"key":"2026012115130926900_ref47","article-title":"Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism","author":"National Institute for Health and Clinical Excellence","year":"2010"},{"key":"2026012115130926900_ref48","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.hrthm.2016.03.024","article-title":"Is transesophageal echocardiogram mandatory in patients undergoing ablation of atrial fibrillation with uninterrupted novel oral anticoagulants? Results from a prospective multicenter registry","volume":"13","author":"Di Biase","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026012115130926900_ref49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4244\/EIJ-D-21-00713","article-title":"Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry","volume":"18","author":"Sebag","year":"2022","journal-title":"EuroIntervention"},{"key":"2026012115130926900_ref50","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.amjcard.2018.02.045","article-title":"Feasibility of left atrial appendage occlusion for left atrial appendage thrombus in patients with persistent atrial fibrillation","volume":"121","author":"Lee","year":"2018","journal-title":"Am J Cardiol"},{"key":"2026012115130926900_ref51","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"2026012115130926900_ref52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.carrev.2022.05.017","article-title":"Review of late-breaking trials from CRT 2022","volume":"40","author":"Bhogal","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"2026012115130926900_ref53","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.carrev.2023.04.017","article-title":"Review of late-breaking trials from CRT 2023","volume":"53","author":"Merdler","year":"2023","journal-title":"Cardiovasc Revasc Med"},{"key":"2026012115130926900_ref54","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/14779072.2018.1510316","article-title":"Antithrombotic strategies after interventional left atrial appendage closure: an update","volume":"16","author":"Chen","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026012115130926900_ref55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2459\/JCM.0000000000001394","article-title":"Impact and predictors of device-related thrombus after percutaneous left atrial appendage closure","volume":"24","author":"Branca","year":"2023","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2026012115130926900_ref56","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.31083\/j.rcm2204128","article-title":"Clinical and multi-modality imaging approach in the selection of patients for left atrial appendage closure","volume":"22","author":"Riegler","year":"2021","journal-title":"Rev Cardiovasc Med"},{"key":"2026012115130926900_ref57","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.jacc.2023.08.010","article-title":"Network meta-analysis of initial antithrombotic regimens after left atrial appendage occlusion","volume":"82","author":"Carvalho","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026012115130926900_ref58","doi-asserted-by":"publisher","DOI":"10.25270\/jic\/24.00239","article-title":"Left atrial appendage occlusion in patients with non-valvular atrial fibrillation and cerebral amyloid angiopathy: insights from the LOGIC (left Atrial Appendage Occlusion in patients with Gastrointestinal or IntraCranial Bleeding) international multicenter registry","volume":"37","author":"Ronco","year":"2025","journal-title":"J Invasive Cardiol"},{"key":"2026012115130926900_ref59","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/europace\/euac270","article-title":"Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study","volume":"25","author":"Betts","year":"2023","journal-title":"Europace"},{"key":"2026012115130926900_ref60","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer Amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"2026012115130926900_ref61","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/europace\/euad049","article-title":"Outcomes of percutaneous left atrial appendage occlusion device implantation in atrial fibrillation patients based on underlying stroke risk","volume":"25","author":"Messele","year":"2023","journal-title":"Europace"},{"key":"2026012115130926900_ref62","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"key":"2026012115130926900_ref63","doi-asserted-by":"publisher","first-page":"877","DOI":"10.4244\/EIJ-D-17-00042","article-title":"Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry","volume":"13","author":"Bergmann","year":"2017","journal-title":"EuroIntervention"},{"key":"2026012115130926900_ref64","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1136\/heartjnl-2015-309150","article-title":"Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation","volume":"102","author":"Berti","year":"2016","journal-title":"Heart"},{"key":"2026012115130926900_ref65","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.4244\/EIJ-D-16-00726","article-title":"Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy","volume":"12","author":"Korsholm","year":"2017","journal-title":"EuroIntervention"},{"key":"2026012115130926900_ref66","doi-asserted-by":"publisher","first-page":"867","DOI":"10.4244\/EIJ-D-17-00493","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical\/echocardiographic data from a global prospective observational study","volume":"13","author":"Landmesser","year":"2017","journal-title":"EuroIntervention"},{"key":"2026012115130926900_ref67","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jcin.2016.11.029","article-title":"Incidence and clinical impact of device-associated thrombus and peri-device leak following left atrial appendage closure with the Amplatzer cardiac plug","volume":"10","author":"Saw","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2026012115130926900_ref68","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial","volume":"143","author":"Kar","year":"2021","journal-title":"Circulation"},{"key":"2026012115130926900_ref69","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.hrthm.2021.02.022","article-title":"Left atrial appendage closure in patients with prohibitive anatomy: insights from PINNACLE FLX","volume":"18","author":"Ellis","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026012115130926900_ref70","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.jacep.2020.06.028","article-title":"The Watchman FLX device: first European experience and feasibility of intracardiac echocardiography to guide implantation","volume":"6","author":"Korsholm","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"2026012115130926900_ref71","doi-asserted-by":"publisher","first-page":"E348","DOI":"10.25270\/jic\/21.00240","article-title":"True efficacy of LAA closure: patient outcomes on long-term single-antiplatelet or no therapy: insights from the EWOLUTION registry","volume":"34","author":"Paitazoglou","year":"2022","journal-title":"J Invasive Cardiol"},{"key":"2026012115130926900_ref72","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of device-related thrombus following percutaneous left atrial appendage occlusion","volume":"78","author":"Simard","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026012115130926900_ref73","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.jacep.2023.04.013","article-title":"Enhanced thromboresistance and endothelialization of a novel fluoropolymer-coated left atrial appendage closure device","volume":"9","author":"Saliba","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2026012115130926900_ref74","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/europace\/euad237","article-title":"Mechanisms, predic,tors, and evolution of severe peri-device leaks with two different left atrial appendage occluders","volume":"25","author":"Lakkireddy","year":"2023","journal-title":"Europace"},{"key":"2026012115130926900_ref75","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.jacep.2021.06.002","article-title":"Radiofrequency energy applications targeting significant residual leaks after Watchman implantation: a prospective, Multicenter experience","volume":"7","author":"Della Rocca","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"2026012115130926900_ref76","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1016\/j.jcin.2023.10.046","article-title":"Device-related thrombus after left atrial appendage occlusion: clinical impact, predictors, classification, and management","volume":"16","author":"Alkhouli","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2026012115130926900_ref77","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/j.jcin.2022.09.001","article-title":"Peridevice leak after transcatheter left atrial appendage occlusion: an analysis of the Amulet IDE trial","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2026012115130926900_ref78","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ccep.2019.10.003","article-title":"Left atrial appendage closure: prevention and management of periprocedural and postprocedural complications","volume":"12","author":"Wilkins","year":"2020","journal-title":"Card Electrophysiol Clin"},{"key":"2026012115130926900_ref79","doi-asserted-by":"publisher","first-page":"e942","DOI":"10.4244\/EIJ-D-19-01027","article-title":"WATCHMAN versus ACP or Amulet devices for left atrial appendage occlusion: a sub-analysis of the multicentre LAARGE registry","volume":"16","author":"Ledwoch","year":"2020","journal-title":"EuroIntervention"},{"key":"2026012115130926900_ref80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.hrthm.2017.11.015","article-title":"Left atrial appendage angiography is associated with the incidence and number of magnetic resonance imaging-detected brain lesions after percutaneous catheter-based left atrial appendage closure","volume":"15","author":"Rillig","year":"2018","journal-title":"Heart Rhythm"},{"key":"2026012115130926900_ref81","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa2308440","article-title":"Trial of early minimally invasive removal of intracerebral hemorrhage","volume":"390","author":"Pradilla","year":"2024","journal-title":"N Engl J Med"},{"key":"2026012115130926900_ref82","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S1474-4422(21)00298-2","article-title":"Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial","volume":"20","author":"Schreuder","year":"2021","journal-title":"Lancet Neurol"},{"key":"2026012115130926900_ref83","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S1474-4422(21)00264-7","article-title":"Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial","volume":"20","author":"SoSTART Collaboration","year":"2021","journal-title":"Lancet Neurol"},{"key":"2026012115130926900_ref84","volume-title":"NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH","author":"Population Health Research Institute","year":"2017"},{"key":"2026012115130926900_ref85","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0140-6736(25)00333-2","article-title":"Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial","volume":"405","author":"Veltkamp","year":"2025","journal-title":"Lancet"},{"key":"2026012115130926900_ref86","doi-asserted-by":"publisher","first-page":"961000","DOI":"10.3389\/fcvm.2022.961000","article-title":"Meta-analysis of oral anticoagulants and adverse outcomes in atrial fibrillation patients after intracranial hemorrhage","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026012115130926900_ref87","doi-asserted-by":"publisher","first-page":"CD012144","DOI":"10.1002\/14651858.CD012144.pub3","article-title":"Antithrombotic treatment after stroke due to intracerebral haemorrhage","volume":"2023","author":"Cochrane","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2026012115130926900_ref88","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/europace\/euaa423","article-title":"Antithrombotic therapy for stroke prevention in patients with atrial fibrillation who survive an intracerebral haemorrhage: results of an EHRA survey","volume":"23","author":"Ivany","year":"2021","journal-title":"Europace"},{"key":"2026012115130926900_ref89","volume-title":"EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)","author":"Population Health Research Institute","year":"2019"},{"key":"2026012115130926900_ref90","volume-title":"PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation","author":"Imperial College London","year":"2019"},{"key":"2026012115130926900_ref91","volume-title":"Avoiding Anticoagulation After IntraCerebral Haemorrhage","author":"University Hospital Lille","year":"2019"},{"key":"2026012115130926900_ref92","volume-title":"Study of Antithrombotic Treatment After IntraCerebral Haemorrhage","author":"Oslo University Hospital","year":"2018"},{"key":"2026012115130926900_ref93","volume-title":"Anticoagulation in ICH Survivors for Stroke Prevention and Recovery","author":"Yale University and National Institute of Neurological Disorders and Stroke","year":"2020"},{"key":"2026012115130926900_ref94","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/S0140-6736(23)02025-1","article-title":"Anticoagulation in patients with cerebral amyloid angiopathy","volume":"402","author":"Shoamanesh","year":"2023","journal-title":"Lancet"},{"key":"2026012115130926900_ref95","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the Management of Patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"2026012115130926900_ref96","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcin.2020.09.051","article-title":"Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation","volume":"14","author":"Nielsen-Kudsk","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2026012115130926900_ref97","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4244\/EIJ-D-17-00201","article-title":"Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study","volume":"13","author":"Nielsen-Kudsk","year":"2017","journal-title":"EuroIntervention"},{"key":"2026012115130926900_ref98","volume-title":"Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding","author":"Jena University Hospital","year":"2020"},{"key":"2026012115130926900_ref99","volume-title":"Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage","author":"Karolinska Institutet and Abbott Medical Devices","year":"2017"},{"key":"2026012115130926900_ref100","volume-title":"Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy","author":"Charite University Berlin Germany","year":"2018"},{"key":"2026012115130926900_ref101","volume-title":"Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients","author":"National Institute of Cardiology Warsaw Poland and Medical Research Agency Poland","year":"2022"},{"key":"2026012115130926900_ref102","volume-title":"Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease","author":"Eitel","year":"2022"},{"key":"2026012115130926900_ref103","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10840-022-01141-z","article-title":"Left atrial appendage closure in patients with intracranial hemorrhage","volume":"64","author":"Garg","year":"2022","journal-title":"J Interv Card Electrophysiol"},{"key":"2026012115130926900_ref104","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/svn-2024-003142","article-title":"Left atrial appendage closure for patients with atrial fibrillation at high intracranial haemorrhagic risk","volume":"10","author":"Abramovitz Fouks","year":"2025","journal-title":"Stroke Vasc Neurol"},{"key":"2026012115130926900_ref105","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1093\/europace\/euz199","article-title":"Oral anticoagulation in patients with atrial fibrillation and acute ischaemic stroke: design and baseline data of the prospective multicentre berlin atrial fibrillation registry","volume":"21","author":"Haeusler","year":"2019","journal-title":"Europace"},{"key":"2026012115130926900_ref106","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00415-021-10866-2","article-title":"Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter berlin atrial fibrillation registry","volume":"269","author":"Tutuncu","year":"2022","journal-title":"J Neurol"},{"key":"2026012115130926900_ref107","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/jnnp-2021-328391","article-title":"Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation","volume":"93","author":"Polymeris","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026012115130926900_ref108","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/eurheartj\/ehad200","article-title":"Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation","volume":"44","author":"Benz","year":"2023","journal-title":"Eur Heart J"},{"key":"2026012115130926900_ref109","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1161\/STROKEAHA.121.038239","article-title":"Recurrent ischemic stroke and bleeding in patients with atrial fibrillation who suffered an acute stroke while on treatment with nonvitamin K antagonist oral anticoagulants: the RENO-EXTEND study","volume":"53","author":"Paciaroni","year":"2022","journal-title":"Stroke"},{"key":"2026012115130926900_ref110","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ana.25700","article-title":"Ischemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation","volume":"87","author":"Seiffge","year":"2020","journal-title":"Ann Neurol"},{"key":"2026012115130926900_ref111","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jcin.2024.04.012","article-title":"Left atrial appendage occlusion in patients with anticoagulation failure vs anticoagulation contraindication","volume":"17","author":"Aarnink","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"2026012115130926900_ref112","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/eurheartj\/ehac544.632","article-title":"Left atrial appendage occlusion versus standard of care in patients with atrial fibrillation and a prior thrombo-embolic event despite oral anticoagulant therapy: a propensity score matched comparison","volume":"43","author":"Maarse","year":"2022","journal-title":"Eur Heart J"},{"key":"2026012115130926900_ref113","volume-title":"The Fourth Left Atrial Appendage Occlusion Study","author":"Hamilton Health Sciences Corporation","year":"2023"},{"key":"2026012115130926900_ref114","volume-title":"Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy","author":"Insel Gruppe AG University Hospital Bern","year":"2024"},{"key":"2026012115130926900_ref115","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1474-4422(22)00436-7","article-title":"Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial","volume":"22","author":"Jensen","year":"2023","journal-title":"Lancet Neurol"},{"key":"2026012115130926900_ref116","volume-title":"STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study","author":"Nippon Medical School and Daiichi Sankyo Co. Ltd","year":"2018"},{"key":"2026012115130926900_ref117","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s11886-020-01388-w","article-title":"Permanent bilateral carotid filters for stroke prevention in atrial fibrillation","volume":"22","author":"De Potter","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"2026012115130926900_ref118","volume-title":"Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation","author":"Javelin Medical and Population Health Research Institute","year":"2023"},{"key":"2026012115130926900_ref119","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1016\/j.jacc.2021.04.036","article-title":"Prevalence of left atrial thrombus in anticoagulated patients with atrial fibrillation","volume":"77","author":"Lurie","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026012115130926900_ref120","doi-asserted-by":"publisher","first-page":"e937063","DOI":"10.12659\/AJCR.937063","article-title":"Percutaneous left atrial appendage closure with the LAmbre device protected by a cerebral protection system in a 76-year-old man with persistent left atrial appendage thrombus","volume":"23","author":"Popescu","year":"2022","journal-title":"Am J Case Rep"},{"key":"2026012115130926900_ref121","doi-asserted-by":"publisher","first-page":"884","DOI":"10.5603\/CJ.2022.0086","article-title":"Percutaneous left atrial appendage closure containing thrombus","volume":"29","author":"Mohandes","year":"2022","journal-title":"Cardiol J"},{"key":"2026012115130926900_ref122","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1378\/chest.15-1719","article-title":"Stroke, major bleeding, and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease: a meta-analysis of observational studies","volume":"149","author":"Dahal","year":"2016","journal-title":"Chest"},{"key":"2026012115130926900_ref123","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jacc.2019.10.059","article-title":"Oral anticoagulation for patients with atrial fibrillation on long-term hemodialysis","volume":"75","author":"Kuno","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026012115130926900_ref124","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1053\/j.ajkd.2021.02.328","article-title":"Oral anticoagulant agents in patients with atrial fibrillation and CKD: a systematic review and pairwise network meta-analysis","volume":"78","author":"Su","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2026012115130926900_ref125","volume-title":"Left Atrial Appendage Occlusion vs. Usual Care in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease","author":"University of Magdeburg","year":"2014"},{"key":"2026012115130926900_ref126","volume-title":"The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial","author":"Population Health Research Institute","year":"2016"},{"key":"2026012115130926900_ref127","doi-asserted-by":"publisher","first-page":"396","DOI":"10.34067\/KID.0004082021","article-title":"Left atrial appendage closure: an alternative to anticoagulation for stroke prevention in patients with kidney disease","volume":"3","author":"Vallurupalli","year":"2022","journal-title":"Kidney 360"},{"key":"2026012115130926900_ref128","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1160\/TH15-04-0350","article-title":"Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study","volume":"115","author":"Martinez","year":"2016","journal-title":"Thromb Haemost"},{"key":"2026012115130926900_ref129","doi-asserted-by":"publisher","first-page":"e005969","DOI":"10.1161\/CIRCOUTCOMES.119.005969","article-title":"Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"13","author":"Ozaki","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026012115130926900_ref130","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0140-6736(03)12228-3","article-title":"Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis","volume":"361","author":"Rothwell","year":"2003","journal-title":"Lancet"}],"container-title":["European Stroke Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/11\/1\/aakaf018\/66196177\/aakaf018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/11\/1\/aakaf018\/66196177\/aakaf018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:17:51Z","timestamp":1769026671000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/esj\/article\/doi\/10.1093\/esj\/aakaf018\/8407781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/esj\/aakaf018","relation":{},"ISSN":["2396-9873","2396-9881"],"issn-type":[{"value":"2396-9873","type":"print"},{"value":"2396-9881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1,1]]},"article-number":"aakaf018"}}